2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Epidemiology Outcomes

ARDS Subtyping: The Future of Guiding Clinical Intervention

Tools for Precision Therapy for Critical Illness (ARDS, Sepsis): Correlating to Treatment Effect

Monday, March 23, 2026
1:50 PM - 2:00 PM Central Time
Location: W181

  • Diego A. Rey, PhD

    Endpoint Health Inc

    Disclosure(s): Gemini Therapeutics: Owner/Co-Owner Founder/Co-Founder (Ongoing), Salary (Ongoing)